MIA
CVAC

Milestone Investment Advisors’s CureVac CVAC Stock Holding History

Milestone Investment Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$103 – 198
2023
Q3 		$103 Buy
+15
New +$132 ﹤0.01% 438
2023
Q2 		– Sell
-15
Closed -$105 – 193
2023
Q1 		$105 Buy
+15
New +$131 ﹤0.01% 441

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Milestone Investment Advisors's CVAC Position: Q4 2023 in Review

Milestone Investment Advisors sold out of CureVac (CVAC) in Q4 2023, closing a stake of 15 shares — an estimated $103 sold.

Milestone Investment Advisors first reported a position in CVAC in Q1 2023 and held it in 2 quarters. The position peaked at $105 in Q1 2023. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

  • Milestone Investment Advisors reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
  • Milestone Investment Advisors sold 15 CureVac shares in Q4 2023, an estimated $103.
  • Milestone Investment Advisors first reported a position in CureVac in Q1 2023 and held it in 2 quarters.
  • Milestone Investment Advisors's CureVac position peaked at $105 in Q1 2023.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Milestone Investment Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.